OncoTAb Inc.
OncoTAb develops a continuum of products from early detection to treatment of epithelial cancers. Current products on the market and under development address unmet needs in the detection and treatment of pancreatic cancer as well as triple negative and metastatic breast cancer.
Company Location
9319 Robert D. Snyder Road, Suite 202
Charlotte
NC
28223
Phone
County
Region
Company Details
Company type
Year founded
2010
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Potential end market(s)
Products on market
Agkura Personal Score - test to detect growth of epithelial cancers (breast, pancreas, etc.)
Products under development
Radiolabeled Theranostic, Bi-specific T cell engager